Investigational vaccine for genital herpes (HSV-2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational vaccine for genital herpes (HSV-2), covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions [Phase 1]